Filamin A increases aggressiveness of human neuroblastoma.

Bandaru, Sashidar; Prajapati, Bharat; Juvvuna, Prasanna Kumar; Dosa, Sandor; Kogner, Per; Johnsen, John I; Kanduri, Chandrasekhar; Akyürek, Levent M

Bandaru, Sashidar; Prajapati, Bharat; Juvvuna, Prasanna Kumar; Dosa, Sandor; Kogner, Per; Johnsen, John I; Kanduri, Chandrasekhar; Akyürek, Levent M.

Afiliação

Bandaru S; Department of Clinical Pathology, Sahlgrenska University Hospital, Region Västra Götaland, Göteborg, Sweden.
Prajapati B; Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden.
Juvvuna PK; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden.
Dosa S; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden.
Kogner P; Department of Clinical Pathology, Sahlgrenska University Hospital, Region Västra Götaland, Göteborg, Sweden.
Johnsen JI; Childhood Cancer Research Unit, Department of Women´s and Children's Health, Karolinska Institute, Stockholm, Sweden.
Kanduri C; Childhood Cancer Research Unit, Department of Women´s and Children's Health, Karolinska Institute, Stockholm, Sweden.
Akyürek LM; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden.

Neurooncol Adv ; 4(1): vdac028, 2022.

Article em En | MEDLINE | ID: mdl-35441138

Palavras-chave

MYCN; STAT3; filamin; high-risk; neuroblastoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Neurooncol Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google